Objectives: We evaluated the reliability of sonographic criteria in selecting solid renal masses for percutaneous fine-needle biopsy.
Methods: In study 1 (intraoperative ultrasound study), we prospectively examined 100 consecutive patients scheduled for partial/radical nephrectomy by using two different high-resolution probes (Philips HDI 5000, CT8-4, L12-5; 4-12MHz). The main tumor was intraoperatively evaluated by B-mode and power Doppler sonography. Morphologic characteristics seen on ultrasound were categorized in (non-)homogenous and (non-)cystic renal masses and were related to findings of pathological examination. Study 1 provided the selection criteria for study 2. In study 2 (percutaneous biopsy study), under local anesthesia and with the use of an 18-G needle, we prospectively performed two to three sonographically guided percutaneous biopsies in 30 consecutive patients whose tumors appeared to be homogenous and noncystic according to the sonograph (convex array 3.5MHz, HDI 5000, C5-2 and Falcon 2101 EXL, B+K Medical).
Results: In the ultrasound study, only 16 (22.9%) of the 76 clear-cell carcinomas but all 9 (100%) oncocytoma appeared homogenous and noncystic on high-resolution intraoperative ultrasound. By applying these results to 30 patients of study 2 (18 men, 12 women; aged 63+/-7.7 yr, tumor size 29+/-11.3mm) who met these sonographic criteria on preoperative transabdominal ultrasound, we bioptically diagnosed 8 (26.7%) benign tumors; 25 of 30 (83.3%) patients were accurately diagnosed. Small tumors (<3cm), decreased breathing compliance, and medially located renal lesions seem to negatively influence biopsy results.
Conclusions: Kidney tumors that appear noncystic and homogenous on preoperative ultrasound are more likely to be of benign origin. Ultrasound-guided percutaneous biopsy of these solid renal masses could determine renal tumor patients for whom surveillance might be an option. However, experienced and dedicated histopathologic evaluation remains crucial to observe patients with clearly benign biopsy results. All even slightly questionable biopsy findings require surgical exploration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.eururo.2007.01.078 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to Letter for the Article, the Impact of Sestamibi Scan on Clinical Decision-Making for Renal Masses: An Observational Single-center Study. Yong, Courtney; Tong, Yan; Tann, Mark; Sundaram, Chandru P. Indian Journal of Urology. 40(3):151-155, Jul-Sep 2024.
Indian J Urol
January 2025
Department of Urology, Indiana University, IN, United States.
Concordance of surgical treatment selection with the AUA guidelines for localized renal masses.
Urol Oncol
January 2025
College of Human Medicine, Michigan State University, Grand Rapids, MI; Division of Urology, Corewell Health West, Grand Rapids, MI. Electronic address:
Objective: To examine and evaluate guideline concordance of surgical treatment selection at a community-based health system. The AUA guidelines provide specific guidance regarding appropriate utilization of radical nephrectomy (RN) and partial nephrectomy (PN). However, nearly 40% of patients did not fit a guideline-specified scenario in a prior report.
View Article and Find Full Text PDFCECT-Based Radiomic Nomogram of Different Machine Learning Models for Differentiating Malignant and Benign Solid-Containing Renal Masses.
J Multidiscip Healthc
January 2025
Department of Nuclear Medicine, The First People's Hospital of Yunnan Province, the Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, 650032, People's Republic of China.
Objective: This study aimed to explore the value of a radiomic nomogram based on contrast-enhanced computed tomography (CECT) for differentiating benign and malignant solid-containing renal masses.
Materials And Methods: A total of 122 patients with pathologically confirmed benign (n=47) or malignant (n=75) solid-containing renal masses were enrolled in this study. Radiomic features were extracted from the arterial, venous and delayed phases and further analysed by dimensionality reduction and selection.
Lack of effect of renal function on uptake of 99mTc-sestamibi in renal masses.
Nucl Med Commun
January 2025
Molecular Imaging and Therapeutics, Department of Radiology, University of North Carolina, Chapel Hill, North Carolina.
Objective: The appropriate clinical management of indeterminate small renal masses can be improved based on accurate risk stratification. This study aimed to investigate the impact of renal function on the uptake of technetium-99m (99mTc)-sestamibi, a widely available imaging agent that can be utilized to identify oncocytomas and other benign/indolent renal masses.
Methods: A retrospective cohort study was conducted, involving 100 consecutive patients who underwent 99mTc-sestamibi single-photon emission computed tomography/computed tomography.
Tumour size is associated with growth rates of >0.5 cm/year and delayed intervention in small renal masses in patients on active surveillance.
BJU Int
January 2025
Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Objective: To evaluate the association between tumour size and the growth rate (GR) of small renal masses (SRMs) in patients managed by active surveillance (AS).
Materials And Methods: We queried the prospective, multi-institutional Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) registry for patients on AS with an imaging interval of ≥6 months, identifying 456 patients. We tracked tumour size over time; a GR >0.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!